Whitehawk Therapeutics WHWK
NASDAQ WHWK
$3.24 +0.16 (+5.19%)
At close: Nov 11, 2026 · 4:00 PM EST

Whitehawk Therapeutics (WHWK) Preferred Stock Liabilities (2016)

Updated

Whitehawk Therapeutics (WHWK) reported Preferred Stock Liabilities of $73.76 million for Q4 2016.

Analysis

Whitehawk Therapeutics (WHWK) Preferred Stock Liabilities (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Whitehawk Therapeutics 289.11 Mn 119.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 73.76 Mn
Sep 30, 2016 -224,224.00
API Access

Whitehawk Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=WHWK&period=max&api_key=YOUR_API_KEY